* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *
Full Coverage

Merck Halts Achieve Study

wsj.com
May 21, 2008
        
Story Timeline:  145 days

Word Count: 206 | Companies Featured in This Article: Merck, Schering-Plough Merck & Co. discontinued its Achieve study nearly two months after patient enrollment was halted to study data from other studies measuring artery thickness. Those studies included Enchance, a controversial study... [read full story]                    

Add Comment
Latest article on this story:

Merck ends cholesterol drug study

 pharmiweb.co.uk May 23, 2008
First article on this story:

ACHIEVE Imaging Study Discontinued

 merck.com May 21, 2008
Selected publications with coverage of this story:
foxreno.com physorg.com nbcsandiego.com nbc11.com theconservativevoice.com nbc10.com alternet.org marketwatch.com startribune.com modbee.com foxnews.com wptz.com
RELATED
Found 44 documents:
                   

Merck Can't ACHIEVE Anything (at Motley Fool)

yahoo.com
May 22, 2008
        

By Brian Orelli May 22, 2008 Comments (0) What do you get when you combine a trial design that failed to show improved patient outcomes, two cholesterol-lowering drugs, and an FDA not-approvable letter? Merck (NYSE: MRK) announced yesterday that it was cancelling its ACHIEVE (An Assessment of...

                   

Has Merck Learned Anything from Vioxx and Vytorin?

alternet.org
May 22, 2008
        

It's getting tough to find any Merck drug that can hold up to scrutiny. Merck transposed its own clinical study results of 34 deaths in the Vioxx group and 12 in the placebo group to 29 deaths in the Vioxx group and 17 in the placebo group when it submitted data to the FDA, write Bruce Psaty, MD,...

Cholesterol Drug Testing Comes To A Halt

local10.com
May 22, 2008
        

Merck stops a study of what it hoped would be a new way to treat high cholesterol. ... Merck Gives Up On Drug After FDA Ruling TRENTON, N.J. -- The drugmaker said Wednesday an advisory committee recommended ending the study of cholesterol drug MK-0524A, two months after...

Cholesterol Drug Testing Comes To A Halt

foxreno.com
May 22, 2008
        

Merck stops a study of what it hoped would be a new way to treat high cholesterol. ... Merck Gives Up On Drug After FDA Ruling TRENTON, N.J. -- The drugmaker said Wednesday an advisory committee recommended ending the study of cholesterol drug MK-0524A, two months after...

Cholesterol Drug Testing Comes To A Halt

news4jax.com
May 22, 2008
        

Merck Gives Up On Drug After FDA Ruling TRENTON, N.J. -- The drugmaker said Wednesday an advisory committee recommended ending the study of cholesterol drug MK-0524A, two months after the same scientists urged enrollment of more patients be put on hold. The halted study, called ACHIEVE, used...

Study Stops Early On Cholesterol Drug

koco.com
May 22, 2008
        

Merck Gives Up On Drug After FDA Ruling TRENTON, N.J. -- The drugmaker said Wednesday an advisory committee recommended ending the study of cholesterol drug MK-0524A, two months after the same scientists urged enrollment of more patients be put on hold. The halted study, called ACHIEVE, used...

Study Stops Early On Cholesterol Drug

nbc10.com
May 22, 2008
        

Merck Gives Up On Drug After FDA Ruling TRENTON, N.J. -- The drugmaker said Wednesday an advisory committee recommended ending the study of cholesterol drug MK-0524A, two months after the same scientists urged enrollment of more patients be put on hold. The halted study, called ACHIEVE, used...

Study Stops Early On Cholesterol Drug

4029tv.com
May 22, 2008
        

Merck Gives Up On Drug After FDA Ruling TRENTON, N.J. -- Merck has halted a study of an experimental drug it had touted as key to energizing its sagging cholesterol franchise. The announcement came barely three weeks after U.S. regulators refused to allow sales of the drug. The drugmaker said an...

Study Stops Early On Cholesterol Drug

nbc11.com
May 22, 2008
        

Merck had hoped a new anti-cholestrol drug would continue its franchise. Instead, testing is called to an end. ... Merck Gives Up On Drug After FDA Ruling TRENTON, N.J. -- Merck has halted a study of an experimental drug it had touted as key to energizing its sagging...

Study Stops Early On Cholesterol Drug

nbc4.tv
May 22, 2008
        

Merck Gives Up On Drug After FDA Ruling TRENTON, N.J. -- Merck has halted a study of an experimental drug it had touted as key to energizing its sagging cholesterol franchise. The announcement came barely three weeks after U.S. regulators refused to allow sales of the drug. The drugmaker said an...

1 2 3 4 5 next »

               

Related categories